Guildford, UK, 10 July 2015: ReNeuron Group plc, a leading UK-based cell therapy company, is pleased to announce that it has raised a total of £68.4 million, before expenses, through a conditional placing (the “Placing”) that will enable the Company to build on the considerable recent progress achieved across its therapeutic programmes.